Marketing In Brief
This article was originally published in The Rose Sheet
Executive Summary
Avon: Fourth quarter launch of Anew Clinical Wrinkle Relaxer Concentrate will likely be the "single biggest product" launch in the company's history, CEO Andrea Jung predicts during the Goldman Sachs Annual Global Consumer Products Conference May 19. Also slated to launch in Q4 is Retroactive Fortifier, while Anew Clinical Micro-Exfoliant and Solutions Pure Porefection will roll out in the third quarter, Jung says. Products are expected to fuel strong performance in Avon's skin care business, which was up 36% in Q1 (1"The Rose Sheet" May 3, 2004, In Brief)...
You may also be interested in...
Avon Q1
Beauty division sales advanced 23% in the first quarter, driven by a 36% gain in skin care revenue, the company announces April 30. Launch of Anew Clinical 2-Step Facial Peeland Line and Wrinkle Correctorand the restage of Retroactive Plus generated combined sales in excess of $50 mil. during the period, CEO Andrea Jung reports. U.S. sales increased 7%, while operating profit in the unit declined 7%, due to a planned non-beauty clearance event. Consolidated net sales were up 19.5% to $1.75 bil. on a reported basis and increased 14% in local currencies. Net income jumped 49.8% to $148.1 mil., as the year-ago period included expenses of $18 mil...
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle